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INTRODUCTION
Overactive bladder (OAB) is described by the Inter­
national Continence Society as ‘the feeling of  urinary 
urgency, with or without urge incontinence, associated 
with increased urination frequency at day and night’ [1]. 
OAB is defined by involuntary bladder contractions that 
occur during bladder filling despite the patient’s attempt to 
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compress them [2]. The incidence of OAB, which has negative 
effects on quality of life, sleep quality, and mental health, 
increases in parallel with advancing age. The prevalence 
of OAB is high; the disease is known to affect millions of 
people worldwide. Despite such a high prevalence, millions of 
patients with OAB are not diagnosed or treated [3­5]. 
In biological systems, the loss of  balance between 
reactive oxygen species (ROS) and the antioxidant defense 
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mechanism against them is defined as oxidative stress. An 
increase in ROS levels leads to damage on cell membranes, 
disruption of the structure and function of intracellular 
proteins, and structural damage to DNA, leading to cell 
damage. Lipid peroxidation plays a role in the pathogenesis 
of many diseases with tissue damage, and malondialdehyde 
(MDA), a product of lipid peroxidation, is used as a marker 
of oxidative stress [6,7]. ROS cause more than 20 oxidative 
base damage products in DNA. Among the bases that 
suffer such damage, 8­hydroxy­2'­deoxyguanosine (8­OHdG) 
is a highly sensitive and common marker of  oxidative 
DNA damage [8,9]. 8­OHdG, which is formed as a result 
of  hydroxyl radical attacks on the 8th carbon atom of 
guanine, is cleaved off by DNA repair enzymes, then pass­
ed to the peripheral circulation, and then excreted in the 
urine. 8­OHdG, which is found in the serum and urine, 
is a mutagen formed in DNA by endogenously produced 
ROS during normal oxidative metabolism or by exogenous 
ROS. For this reason, measurement of 8­OHdG is the most 
commonly used method for determining oxidative DNA 
damage [10,11].
Urine and serum levels of 8­OHdG can increase as the 
result of  many pathological conditions, including aging, 
cancer, diabetes, and hypertension [12]. The need for a 
marker to clarify the diagnosis of  OAB and to predict 
treatment success arose because OAB is a symptomatological 
description. There is no pathologic cause that explains 
these symptoms. In this study, we aimed to explain the 
role of oxidative stress in the pathophysiology of OAB in 
women by investigating the levels of 8­OHdG, a marker of 
oxidative DNA damage, and of MDA, an indicator of lipid 
peroxidation.
MATERIALS AND METHODS
1. Selection and evaluation of patients and 
healthy volunteers 
The study was carried out after obtaining the required 
approvals from the Ethics Committee of Ordu University 
Me di cal Faculty Hospital (approval number: 2016/01). A 
total of 90 women were included in the study: 45 female 
patients diagnosed with OAB at Hopa State Hospital Uro­
logy Polyclinic and 45 healthy women without any meta­
bolic disease. All patients and control women gave infor­
med consent and the local ethics committee approval was 
obtained in accordance with the ethical standards of the 
Helsinki Declaration. The patients’ medical history, phy­
sical examination findings, height, weight, and age were 
collected by means of signed standard forms. Women with 
a history of  genitourinary operations, pelvic operations, 
pelvic radiotherapy, chronic neurological or endocrine di­
sease, cystocele, stress urinary incontinence, urinary tract 
infection, drug use leading to urinary symptoms, smoking, 
or any other drug use were excluded from the study. Urine 
specimens taken from all subjects were centrifuged at 3,000 
×g for 10 minutes and the supernatants were separated and 
stored at ­80°C until tested. MDA and 8­OHdG levels were 
measured in 24­hour urine samples for all subjects.
2. Analysis of malondialdehyde levels
The level of MDA, a measure of lipid peroxidation, was 
measured spectrophotometrically by the method described 
by Ohkawa et al. [13]. For each sample, 0.5 mL of 8.1% sodium 
dodecyl sulfate, 0.5 mL of 0.8% thiobarbituric acid, 1.0 mL 
of 10% of trichloroacetic acid, 1.0 mL of 2% glacial acetic 
acid/sodium hydroxide (pH=3.5), and 50 μL of  2% butyl 
hydroxytoluene were added to the urine sample (1.0 mL) 
and this mixture was thoroughly mixed and kept in a water 
bath at 95°C for 60 minutes. After the tubes were chilled, a 
mixture of 4.0 mL of butanol/pyridine (1:15) was added and 
the tubes were centrifuged at 4,000 ×g at 4°C for 10 minutes. 
After centrifugation, the upper organic phase was removed 
and the absorbance was read at 532 nm. The MDA results 
were reported as nmol/mL. 
3. Measurement of urinary 8-hydroxy-2'- 
deoxyguanosine levels
Urinary 8­OHdG levels were determined by means 
of  the enzyme­linked immunosorbent assay (ELISA) 
technique, using human ELISA kits (Cell Biolabs, Inc., San 
Diego, CA, USA) with the test procedure suggested by the 
manufacturer. The 8­OHdG results were reported as ng/mL.
4. Statistical analysis
All data analysis was performed by using the SPSS 
ver. 11.0 software (SPSS Inc., Chicago, IL, USA). The values 
were compared between the groups (patient and control 
groups) by using Student’s t­test according to the results of 
the Levene test and the Shapiro Wilk test for equality of 
variances and the normality supposition, respectively (p>0.05). 
Also, Pearson correlation coefficients were estimated to 
explain the relationships among the analyzed traits (age, 
weight, height, body mass index, MDA, and 8­OHdG). Data 
were presented as sample size (n) and mean with standard 





The demographic characteristics of the study groups are 
presented in Table 1. There were no statistically significant 
differences between the control and patient groups in terms 
of age, height, weight, or body mass index (p>0.05). Urinary 
MDA (3.30±1.29 nmol/L vs. 0.46±0.29 nmol/mL) and urinary 
8­OHdG (66.03±16.49 nmol/L vs. 9.22±5.75 nmol/L) levels were 
significantly higher in the OAB group than in the control 
group (p<0.001) (Figs. 1, 2). 
A significant positive correlation (r=1.000; p<0.001) was 
found between the measurements of 8­OHDG and MDA. 
There was also a significant positive correlation of 45.2% 
between age and weight (p<0.001) and a significant negative 
correlation of 32.1% between age and height (p=0.007). There 
was no statistically significant relationship between the 
other measurement values (p>0.05; Table 2).
DISCUSSION
OAB is a common condition characterized by a symptom 
complex (urgency to urinate, frequent urination, nocturia, 
and urge incontinence) that affects and limits patients’ 
quality of  life. Treatment of  this condition requires an 
understanding of the underlying pathophysiology. Oxidative 
stress may be one possible factor in the pathophysiology 
of  OAB. Previous studies offered the hypothesis that a 
state of oxidative stress may be present in a condition of 
chronic obstruction, and that this results in the production 
of  metabolic end products that injure the phospholipids 
of  the lipid membrane of  the muscle cells. However, 
insufficient evidence has been provided to support such a 
Table 1. Demographic characteristics of the patient and control groups
Characteristic Control group OAB group p-value
Age (y) 52.49±9.55 55.83±11.59 NS
Height (cm) 160.86±4.33 160.23±4.85 NS
Weight (kg) 66.37±8.30 70.51±12.91 NS
BMI (kg/m2) 25.65±6.30 27.47±8.91 NS
Values are presented as mean±standard deviation.
OAB, overactive bladder; BMI, body mass index; NS, not significant.
Table 2. Correlations between examined traits
Variable MDA 8-OHdG Age Height Weight
MDA - 1.000a 0.132 0.187 0.203
8-OHdG - - 0.132 0.187 0.203
Age - - - -0.321a 0.452a
Height - - - - 0.027
MDA, malondialdehyde; 8-OHdG, 8-hydroxy-2'-deoxyguanosine.
a:p=0.01 (2-tailed).
Fig. 1. Urinary MDA levels of the patient and control groups. MDA, 
malondialdehyde; OAB, overactive bladder. a:Significantly different 














































Fig. 2. Urinary 8-OHdG levels of the patient and control groups. 
8-OHdG, 8-hydroxy-2'-deoxyguanosine; OAB, overactive bladder. 
a:Significantly different from the control group (p<0.001).
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hypothesis [14­16]. In the present study, we measured two 
of the most commonly used and accepted markers of the 
presence of oxidative stress in the urine: MDA and 8­OHdG. 
Biomarkers, such as 8­OHdG and MDA are considered 
to be significant indicators of the oxidative stress status 
in organisms. In another study, Dambros et al. [17] used 
hypochlorous acid in pig detrusor to model overactivity 
and found that 8­iso­PGF2α levels were increased in the 
overactive group in relation to oxidative stress. Huang et al. 
[18] studied kaempferol, which is a flavonoid compound that 
is suppressed in oxidative stress and that attenuated bladder 
overactivity in a rat model.
MDA, one of  the most important products of  lipid 
peroxidation, acts on ion exchange from cell membranes, 
leading to cross­linking of  the compounds within the 
membrane and causing negative consequences, such as 
changes in ion permeability and enzyme activity. This occurs 
because the polyunsaturated fatty acids of cell membranes 
are degraded by this process, with the result being the 
disruption of membrane unity. Lipid peroxidation can lead 
to changes in membrane mobility and permeability and 
can also increase the rate of protein deterioration and cell 
lysis [19,20]. In the present study, the MDA concentration 
in the OAB group was significantly higher than that 
in the control group. Alexandre et al. [21] reported that 
increased oxidative stress plays an important role in bladder 
dysfunction. They suggested that mild, chronic ischemia in 
the bladder enhances oxidative stress, leading to detrusor 
overactivity and storage symptoms, which progress to 
detrusor underactivity when bladder ischemia becomes 
severe. Topol et al. [22] reported that OAB is associated 
with oxidative damage in the bladder and the resultant 
production of free radicals. The formation of high amounts 
of oxygen­derivative free radicals has an adverse effect on 
the constituents of biological systems. Chemical and physical 
changes resulting from various internal and external factors 
cause mutations in the structure of DNA, through lethal 
or direct or indirect mutagenesis, by ceasing replication 
and transcription. ROS cause various lesions containing 
8­oxoguanine [23,24]. The level of DNA 8­OHdG and urinary 
8­OHdG is frequently measured in humans as a marker 
of oxidative stress. Repair of oxidative DNA damage and 
repair of the cells in the organism is mostly reflected by 
the excretion of 8­OHdG [25]. In the literature, functional 
changes in bladder ischemia have been reported to be 
associated with impairment of mitochondrial respiration, 
cellular and mitochondrial stress, and activation of  cell 
survival signaling via the PI3K/Akt pathway [26].
Nocchi et al. [27] found that oxidative stress is related to 
increased bladder nerve activity and intravesical pressure 
with H2O2 in a rat model. They also found that increased 
8­OHdG levels in an aged rat group were related to increased 
oxidative stress in the bladder with aging. Matsui et al. [28] 
found that levels of both 8­OHdG and MDA were increased 
in a rat model of atherosclerosis­induced chronic bladder 
ischemia in relation to oxidative stress. They also found 
that Eviprostat, a phytotherapeutic agent, decreased MDA 
and 8­OHdG levels, which was also related to a normalized 
micturition interval. 
Important limitations of  the present study were the 
number of  patients and the lack of  urodynamic exami­
nations or further neurologic examinations. As a second­
stage hospital of our clinic, we could not perform magnetic 
resonance imaging (MRI) or urodynamic investigations. Last, 
an antioxidant therapy could provide a positive control with 
which to compare 8­OHdG and MDA levels after therapy.
CONCLUSIONS
In our study, levels of  both MDA and 8­OHdG were 
higher in patients with OAB than in the control group. 
Although further examinations, such as urodynamic 
investigation, cranial MRI, or electroneuromyography were 
not done, our study showed that oxidative stress is related 
to OAB as a symptom complex (urgency with or without 
incontinence, nocturia, frequency) in women. Additional 
randomized and prospective studies with larger patient 
populations and further examinations are needed.
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